DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
O’Neil PM, Birkenfeld AL, McGowan B. et al.
Efficacy and safety of semaglutide compared with liraglutide and placebo for
weight loss in patients with obesity: A randomised, double-blind, placebo and
active controlled, dose-ranging, phase 2 trial.
Lancet 2018;
392: 637-649
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.